The Role of T Cells in Obesity-Associated Inflammation and Metabolic Disease

키워드

참고문헌 (89)

1. Després JP, "Abdominal obesity and metabolic syndrome", Nature, 444, pp.881~887 (2006)
2. Saltiel AR, "Inflammatory mechanisms linking obesity and metabolic disease", J Clin Invest, 127, pp.1~4 (2017)
3. Esser N, "Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes", Diabetes Res Clin Pract, 105, pp.141~150 (2014)
4. Hotamisligil GS, "Inflammation and metabolic disorders", Nature, 444, pp.860~867 (2006)
5. Mraz M, "The role of adipose tissue immune cells in obesity and low-grade inflammation", J Endocrinol, 222, pp.R113~R127 (2014)
6. Giralt M, "White, brown, beige", brite : different adipose cells for different functions, 2013, pp.154, 2992~3000
7. Morigny P, "Lipid and glucose metabolism in white adipocytes : pathways, dysfunction and therapeutics", Nat Rev Endocrinol, 17, pp.276~295 (2021)
8. Thiam AR, "The why, when and how of lipid droplet diversity", J Cell Sci, 130, pp.315~324 (2017)
9. Shuster A, "The clinical importance of visceral adiposity : a critical review of methods for visceral adipose tissue analysis", Br J Radiol, 85, pp.1~10 (2012)
10. Tchkonia T, "Mechanisms and metabolic implications of regional differences among fat depots", Cell Metab, 17, pp.644~656 (2013)
11. Tabuchi C, "Signaling pathways regulating thermogenesis", Front Endocrinol(Lausanne), 12, pp.595020~ (2021)
12. Cannon B, "Brown adipose tissue : function and physiological significance", Physiol Rev, 84, pp.277~359 (2004)
13. Harms M, "Brown and beige fat : development, function and therapeutic potential", Nat Med, 19, pp.1252~1263 (2013)
14. Demine S, "Mitochondrial uncoupling : a key controller of biological processes in physiology and diseases", Cells, 8, pp.795~ (2019)
15. Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha : direct role in obesity-linked insulin resistance", Science, 259, pp.87~91 (1993)
16. Hotamisligil GS, "Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance", J Clin Invest, 95, pp.2409~2415 (1995)
17. Uysal KT, "Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function", Nature, 389, pp.610~614 (1997)
18. Kahn SE, "Mechanisms linking obesity to insulin resistance and type 2diabetes", Nature, 444, pp.840~846 (2006)
19. Cancello R, "Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss", Diabetes, 54, pp.2277~2286 (2005)
20. Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance", J Clin Invest, 112, pp.1821~1830 (2003)
21. Ferrante AW Jr, "The immune cells in adipose tissue", Diabetes Obes Metab, 15(Suppl 3), pp.34~38 (2013)
22. Ginhoux F, "Monocytes and macrophages : developmental pathways and tissue homeostasis", Nat Rev Immunol, 14, pp.392~404 (2014)
23. 이지혜, "Deciphering Macrophage Phenotypes upon Lipid Uptake and Atherosclerosis", Immune Network, 20(3), pp.1~21 (2020), 대한면역학회[DOI]
24. Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue", J Clin Invest, 112, pp.1796~1808 (2003)
25. Sartipy P, "Monocyte chemoattractant protein 1 in obesity and insulin resistance", Proc Natl Acad Sci U S A, 100, pp.7265~7270 (2003)
26. Kanda H, "MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity", J Clin Invest, 116, pp.1494~1505 (2006)
27. Rull A, "Insulin resistance, inflammation, and obesity : role of monocyte chemoattractant protein-1(or CCL2)in the regulation of metabolism", Mediators Inflamm, 2010, pp.326580~ (2010)
28. Deshmane SL, "Monocyte chemoattractant protein-1(MCP-1) : an overview", J Interferon Cytokine Res, 29, pp.313~326 (2009)
29. Kamei N, "Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance", J Biol Chem, 281, pp.26602~26614 (2006)
30. Strissel KJ, "Adipocyte death, adipose tissue remodeling, and obesity complications", Diabetes, 56, pp.2910~2918 (2007)
31. Lumeng CN, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization", J Clin Invest, 117, pp.175~184 (2007)
32. Wu H, "CD11c expression in adipose tissue and blood and its role in diet-induced obesity", Arterioscler Thromb Vasc Biol, 30, pp.186~192 (2010)
33. Sun K, "Adipose tissue remodeling and obesity", J Clin Invest, 121, pp.2094~2101 (2011)
34. Cinti S, "Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans", J Lipid Res, 46, pp.2347~2355 (2005)
35. Lindhorst A, "Adipocyte death triggers a pro-inflammatory response and induces metabolic activation of resident macrophages", Cell Death Dis, 12, pp.579~ (2021)
36. Halberg N, "Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue", Mol Cell Biol, 29, pp.4467~4483 (2009)
37. Fujisaka S, "Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1α-dependent and HIF-1α-independent manner in obese mice", Diabetologia, 56, pp.1403~1412 (2013)
38. Shan B, "The metabolic ER stress sensor IRE1α suppresses alternative activation of macrophages and impairs energy expenditure in obesity", Nat Immunol, 18, pp.519~529 (2017)
39. Fan R, "Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes", Nat Med, 22, pp.780~791 (2016)
40. Kratz M, "Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages", Cell Metab, 20, pp.614~625 (2014)
41. Wu H, "T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity", Circulation, 115, pp.1029~1038 (2007)
42. Wang Q, "T cells in adipose tissue : critical players in immunometabolism", Front Immunol, 9, pp.2509~ (2018)
43. Raphael I, "T cell subsets and their signature cytokines in autoimmune and inflammatory diseases", Cytokine, 74, pp.5~17 (2015)
44. Mosmann TR, "Th1 and Th2 cells : different patterns of lymphokine secretion lead to different functional properties", Annu Rev Immunol, 7, pp.145~173 (1989)
45. Korn T, "Il-17 and Th17 cells", Annu Rev Immunol, 27, pp.485~517 (2009)
46. Dominguez-Villar M, "Regulatory T cells in autoimmune disease", Nat Immunol, 19, pp.665~673 (2018)
47. Kintscher U, "T-lymphocyte infiltration in visceral adipose tissue : a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance", Arterioscler Thromb Vasc Biol, 28, pp.1304~1310 (2008)
48. Deng T, "Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation", Cell Metab, 17, pp.411~422 (2013)
49. Cho KW, "An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation", Cell Reports, 9, pp.605~617 (2014)
50. Morris DL, "Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice", Diabetes, 62, pp.2762~2772 (2013)
51. Rocha VZ, "Interferon-gamma, a Th1cytokine, regulates fat inflammation : a role for adaptive immunity in obesity", Circ Res, 103, pp.467~476 (2008)
52. Khan IM, "Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency", Atherosclerosis, 233, pp.419~428 (2014)
53. Winer S, "Normalization of obesity-associated insulin resistance through immunotherapy", Nat Med, 15, pp.921~929 (2009)
54. McLaughlin T, "T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans", Arterioscler Thromb Vasc Biol, 34, pp.2637~2643 (2014)
55. Yang H, "Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity : implications for systemic inflammation and insulin resistance", J Immunol, 185, pp.1836~1845 (2010)
56. Zeng Q, "A unique population : adipose-resident regulatory T cells", Front Immunol, 9, pp.2075~ (2018)
57. Feuerer M, "Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters", Nat Med, 15, pp.930~939 (2009)
58. Rausch ME, "Obesity in C57BL", 6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration, 2008, pp.32, 451~463
59. Nishimura S, "CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity", Nat Med, 15, pp.914~920 (2009)
60. Kiran S, "High fat diet-induced CD8+ T cells in adipose tissue mediate macrophages to sustain low-grade chronic inflammation", Front Immunol, 12, pp.680944~ (2021)
61. Tokunaga R, "CXCL9, CXCL10, CXCL11", CXCR3 axis for immune activation-a target for novel cancer therapy, 2018, pp.63, 40~47
62. Bendelac A, "The biology of NKT cells", Annu Rev Immunol, 25, pp.297~336 (2007)
63. Lynch L, "Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production", Immunity, 37, pp.574~587 (2012)
64. Lynch L, "iNKT cells induce FGF21 for thermogenesis and are required for maximal weight loss in GLP1 therapy", Cell Metab, 24, pp.510~519 (2016)
65. Paul S, "Phenotypic and functional plasticity of gamma-delta(γδ)T cells in inflammation and tolerance", Int Rev Immunol, 33, pp.537~558 (2014)
66. Mehta P, "γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice", J Leukoc Biol, 97, pp.121~134 (2015)
67. Kohlgruber AC, "γδ T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis", Nat Immunol, 19, pp.464~474 (2018)
68. Hu B, "γδ T cells and adipocyte IL-17RC control fat innervation and thermogenesis", Nature, 578, pp.610~614 (2020)
69. Bäckhed F, "The gut microbiota as an environmental factor that regulates fat storage", Proc Natl Acad Sci U S A, 101, pp.15718~15723 (2004)
70. Bäckhed F, "Mechanisms underlying the resistance to dietinduced obesity in germ-free mice", Proc Natl Acad Sci U S A, 104, pp.979~984 (2007)
71. Membrez M, "Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice", FASEB J, 22, pp.2416~2426 (2008)
72. Turnbaugh PJ, "An obesity-associated gut microbiome with increased capacity for energy harvest", Nature, 444, pp.1027~1031 (2006)
73. Cani PD, "Metabolic endotoxemia initiates obesity and insulin resistance", Diabetes, 56, pp.1761~1772 (2007)
74. de La Serre CB, "Propensity to high-fat dietinduced obesity in rats is associated with changes in the gut microbiota and gut inflammation", Am J Physiol Gastrointest Liver Physiol, 299, pp.G440~G448 (2010)
75. Cani PD, "Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice", Diabetes, 57, pp.1470~1481 (2008)
76. Caesar R, "Gutderived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice", Gut, 61, pp.1701~1707 (2012)
77. Wang Y, "T-lymphocyte responses to intestinally absorbed antigens can contribute to adipose tissue inflammation and glucose intolerance during high fat feeding", PLoS One, 5, pp.e13951~ (2010)
78. Park C, "Obesity modulates intestinal intraepithelial T cell persistence, CD103 and CCR9 expression, and outcome in dextran sulfate sodium-induced colitis", J Immunol, 203, pp.3427~3435 (2019)
79. Schön MP, "Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E(CD103)-deficient mice", J Immunol, 162, pp.6641~6649 (1999)
80. Uehara S, "A role for CCR9 in T lymphocyte development and migration", J Immunol, 168, pp.2811~2819 (2002)
81. Amiya T, "C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice", Diabetologia, 64, pp.603~617 (2021)
82. Luck H, "Regulation of obesity-related insulin resistance with gut anti-inflammatory agents", Cell Metab, 21, pp.527~542 (2015)
83. Garidou L, "The gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease", Cell Metab, 22, pp.100~112 (2015)
84. Hong CP, "Gutspecific delivery of T-helper 17 cells reduces obesity and insulin resistance in mice", Gastroenterology, 152, pp.1998~2010 (2017)
85. Omenetti S, "The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 cells", Immunity, 51, pp.77~89 (2019)
86. Hinks TSC, "MAIT cell activation and functions", Front Immunol, 11, pp.1014~ (2020)
87. Toubal A, "Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity", Nat Commun, 11, pp.3755~ (2020)
88. He S, "Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease", Nature, 566, pp.115~119 (2019)
89. Müller TD, "Glucagon-like peptide 1(GLP-1)", Mol Metab, 30, pp.72~130 (2019)

관련 논문AI추천